Cellectar Biosciences
NASDAQ: CLRB

Healthcare
Biotechnology
Global Rank
#37346
Country Rank
#4756
Market Cap
16.21 M
Price
0.298
Change (%)
2.16%
Volume
1.79 M
Cellectar Biosciences's latest marketcap:
16.21 M
As of 06/23/2025, Cellectar Biosciences's market capitalization has reached $16.21 M. According to our data, Cellectar Biosciences is the 37346th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 16.21 M |
Revenue (ttm) | 0 |
Net Income (ttm) | -24,543,492 |
Shares Out | 54.36 M |
EPS (ttm) | -0.78 |
Forward PE | 0.00 |
Ex-Dividend Date | n/a |
Earnings Date | 08/12/2025 |
Market Cap Chart
Data Updated: 06/23/2025
Cellectar Biosciences's yearly market capitalization.
Cellectar Biosciences has seen its market value drop from $44.6 M to $16.21 M since 2005, representing a total decrease of 63.67% and an annual compound decline rate (CAGR) of 5.06%.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
06/23/2025 | $16.21 M | 36.59% | 37346 |
12/31/2024 | $12.3 M | -63.82% | 36964 |
12/29/2023 | $34 M | 112.5% | 30377 |
12/30/2022 | $16 M | -60.59% | 33805 |
12/31/2021 | $40.6 M | -27.24% | 28811 |
12/31/2020 | $55.8 M | 164.45% | 24075 |
12/31/2019 | $21.1 M | 185.14% | 26179 |
12/31/2018 | $7.4 M | -65.9% | 28761 |
12/29/2017 | $21.7 M | 233.85% | 25224 |
12/30/2016 | $6.5 M | 3.17% | 26332 |
Company Profile
Cellectar Biosciences was founded in 2002 in United States.
on the Nasdaq Stock Market.
With 11 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Cellectar Biosciences's (CLRB) current market cap?As of 06/23/2025, Cellectar Biosciences (including the parent company, if applicable) has an estimated market capitalization of $16.21 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cellectar Biosciences (CLRB) rank globally by market cap?Cellectar Biosciences global market capitalization ranking is approximately 37346 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.